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Abstract
To investigate the differences in the presence of trigger points (TrPs) and their association with headache-related disability and mood
disorders in people with frequent episodic tension-type headache (TTH) (FETTH) and chronic TTH (CTTH). One hundred twenty-two
individuals with TTH participated. Clinical features of headache (i.e., intensity, duration, and frequency) were recorded on a headache
diary. Headache-related disability was assessed with the Headache Disability Inventory, trait and state anxiety levels with State-Trait
Anxiety Inventory, and depression with the Hospital Anxiety and Depression Scale. TrPs were bilaterally explored in the temporalis,
masseter, suboccipital, upper trapezius, splenius capitis, and sternocleidomastoid muscles. Sixty-two (51%) patients were classified
as FETTH, whereas 60 (49%) were classified as CTTH. Individuals with CTTH showed higher burden of headache and depression
than FETTH (P<0.001). Subjects with FETTH showed similar number of TrPs (total number: 5.9±3.1, active TrPs: 4.7±2.5, and
latent TrPs: 1.2±1.9) than those with CTTH (total number: 5.7±3.2, active TrPs: 4.2±3.0, and latent TrPs: 1.5±1.8). The number of
active TrPs was significantly associated with the burden of headache (r=0.189; P=0.037) and trait anxiety (r=0.273; P=0.005): the
higher the number of active TrPs, the greater the physical burden of headache or the more the trait anxiety level. No association with
the depression was observed. The presence of active TrPs in head and neck/shoulder muscles was similar between individuals with
FETTH andCTTH and associated with the physical burden of headache and trait anxiety levels independently of the subgroup of TTH.
Abbreviations: CTTH = chronic tension-type headache, ETTH = episodic tension-type headache, FETTH = frequent episodic
tension-type headache, HADS = Hospital Anxiety and Depression Scale, HDI = Headache Disability Inventory, ICHD-III =
International Classification of Headache Disorders, third edition, NPRS = Numerical Pain Rate Scale, STAI = State-Trait Anxiety
Inventory, TrP = trigger point, TTH = tension-type headache.
Keywords: anxiety, burden, depression, tension-type headache, trigger points
1. Introduction of muscle and facilitation of nociceptive pain processing.[4] InTension-type headache (TTH) is a common headache disorder
and is an important condition in terms of socioeconomic
impact.[1] The mean global prevalence of TTH in an adult
population is around 42%.[2] The general costs in Europe in 2010
were €13.8 billion for headache, including migraine and TTH.[3]
Current research into the pathogenesis of TTH focuses on the roleEditor: Helen Gharaei.
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fact, it is becoming clear that TTH has a muscle component, and
peripheral and central sensitization mechanisms may play a role
on its development and chronification.[5]
Some studies have previously reported the association between
TTH and impairments in the musculoskeletal system.[6] Among
these impairments, myofascial trigger points (TrPs) have received
particular attention in the headache literature. There is evidence
supporting a potential association between TTH and TrPs[7];
although treatment studies on inhibiting the TrPs are not
conclusive.[4] TrPs are defines as “hypersensitive spots in taut
bands of skeletal muscles which elicit referred pain, autonomic,
and motor symptoms when stimulated.”[8] TrPs are considered
clinically active when the elicited referred pain reproduces
symptoms similar to those the patients suffer from.[8] Previous
studies have reported that the referred pain elicited by active TrPs
in head, neck, and shoulder musculature mimics the headache
pain pattern in individuals with chronic TTH (CTTH)[9–11] and
episodic TTH (ETTH)[12,13]; nevertheless, the number of active
TrPs seems to be lower in the episodic form. This hypothesis was
partly supported by the only study investigating directly the
differences in the presence of active TrPs between subjects with
CTTH and ETTH.[14] Nevertheless, it should be recognized that
the sample sizes of these studies were small and did not
differentiate between frequent or infrequent episodic TTH. New
studies including larger sample sizes and using the most updated
diagnostic criteria of TTH are needed.
In addition, it seems clear that individuals with TTH usually
suffer from mood disorders, particularly anxiety and depres-
[15]
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trigger and aggravating factor of TTH episodes.[16] It is
purported that active TrPs can precipitate or promote TTH by
transmitting nociceptive input to the trigeminocervical nucleus
caudalis.[17] Similarly, stress can also trigger TTH through
hyperalgesic effects by reducing the thresholds to noxious input
from pericranial muscles.[18] Therefore, it is possible that
comorbid anxiety and depression frequently observed in people
with TTH are related to the presence of active TrPs. No previous
study has investigated the relationship between mood disorders
and TrPs in primary headaches. Similarly, the relationship
between active TrPs and headache-related disability has not been
yet investigated in TTH. It would be important to determine if the
presence of TrPs is associated with headache-related disability.
Therefore, the objectives of the present study were to
investigate the differences in the presence of TrPs between
individuals with frequent episodic TTH (FETTH) and CTTH
using the most updated diagnostic criteria, to determine the
association between headache-related disability and active TrPs
in individuals with TTH, and to determine the association
betweenmood disorders (anxiety and depression) and active TrPs
in TTH. Our hypothesis was that people with CTTH would
exhibit greater number of active TrPs, headache-related disabili-
ty, and mood disorders than those with FETTH and that active
TrPs would be associated with higher headache-related disability
and higher mood disorders.2. Methods
2.1. Participants
Subjects with TTHwere recruited from different university-based
hospitals between January 2015 and January 2016. All diagnoses
were made according to the criteria of the International
Classification of Headache Disorders, third edition (ICHD-III
beta, 2013) down to third-digit level (codes 2.2 and 2.3) by
neurologist experts in headache field.[19] They performed a face-
to-face interview followed by a general and neurological
examination. To be included, patients had to describe all the
pain features of TTH: bilateral location, pressing and tightening
pain, moderate intensity (6 on a 10-point Numerical Pain Rate
Scale, NPRS), and no aggravation of pain during physical
activity. Patients should report neither more than one of
photophobia, phonophobia, or mild nausea and neither moder-
ate nor severe nausea nor vomiting as requested by the ICHD-III
diagnostic criteria.[19]
Key elements of the clinical history, including headache-family
history, headache features, temporal pattern, and intake
medication, were assessed. A headache diary for 4 weeks was
used to substantiate the diagnosis and to record the headache
clinical features.[20,21] On this diary, patients registered the
number of days with headache (d/wk), the duration of each
headache attack (h/d), and the headache intensity on an 11-point
NPRS[22] (NPRS; 0: no pain, 10: maximum pain).
Participants were excluded if presented other primary/
secondary headache; medication overuse headache as defined
by the ICHD-III; history of cervical or head trauma (i.e.,
whiplash); pregnancy; history of cervical herniated disk or
cervical osteoarthritis on medical records; any systemic degener-
ative disease, for example, rheumatoid arthritis and lupus
erythematous; comorbid diagnosis of fibromyalgia; receiving
anesthetic block in the previous 6 months; receiving previous
physical treatment in the neck/head the previous 6 months; or2
abuse of caffeine or other stimulating substances. A careful
clinical examination of each patient was conducted to determine
inclusion and exclusion criteria.
All participants read and signed a consent form before their
participation. The study was approved by local Ethics Commit-
tees (URJC 23/2014 [Spain], N20140063 [Denmark], and CESU
5/2015 [Italy]).2.2. Trigger point examination
Participants were evaluated pain-free or, in those with high
frequency of headache, when the intensity of pain was3 points.
TrPs were explored bilaterally in the temporalis, masseter,
suboccipital, sternocleidomastoid, upper trapezius, and splenius
capitis musculature by a clinician with more than 10 years of
experience in TrP diagnosis and blinded to TTH diagnosis
(FETTH or CTTH). The order of evaluation was randomized
between individuals with a 1-minute rest period betweenmuscles.
TrPs diagnosis was performed, in general, according to the
following criteria: presence of a palpable taut band in the muscle,
presence of a painful tender spot in the taut band, local twitch
response on palpation of the taut band, and reproduction of
referred pain.[8] TrP diagnosis was conducted using snapping
palpation (first to locate the taut band, and then moving the
thumb tip back and forth to roll the underlying muscle fibers) to
induce a local twitch response and flat palpation (placing the
padded aspect of the thumb on the spot and applying pressure
against the underlying tissue or bone) to induce the referred pain.
For the suboccipital muscles, the protocol described by
Fernández-de-las-Peñas et al[9] was used. TrP diagnosis in these
muscles was conducted when a pressure applied on the
suboccipital region for 10 seconds elicited referred pain and
contraction of the muscles in the head extension increased the
referred pain.[9] A TrP was considered active when the referred
pain elicited during examination reproduced at least part of the
TTH pain pattern that the subject usually suffered from, and,
therefore, the pain was recognized as a usual and/or familiar pain.
A TrP was considered latent when the pain elicited during
examination did not reproduce any TTH pain feature, and,
therefore, the elicited pain was not recognized as a usual/familiar
pain symptom.[8]2.3. Headache Disability Inventory
The Headache Disability Inventory (HDI) was designed to assess
the burden of headache using 25 items that inquire about the
perceived impact of headache on emotional functioning (e.g.,
“Because of my headaches I feel handicapped”) and daily
activities (e.g., “Because of my headaches I feel restricted in
performing my routine daily activities”).[23] Possible answers for
each item are YES (4 points), SOMETIMES (2 points), andNO (0
point). Thirteen items asses the emotional component of
headache (HDI-E, maximum score: 52), and the remaining
12 items assess the physical component (HDI-P, maximum
score: 48). A greater score suggests a greater burden/disability
of headache. The HDI has exhibited good stability at short
(r=0.93–0.05) and long term (r=0.76–0.83).[24]2.4. State-Trait Anxiety Inventory
The State-Trait Anxiety Inventory (STAI) is a 40-item
scale assessing separate dimensions of state anxiety (items
l–20, STAI-S) as well as trait anxiety (items 21–40, STAI-T).[25,26]
Palacios-Ceña et al. Medicine (2017) 96:13 www.md-journal.comThe STAI-S items assess relatively enduring symptoms of anxiety.
Sample items include “I am worried” and “I am jittery.”
Participants use a 4-point response scale ranging from “not at
all” to “very much,” to indicate the extent to which they
experience each emotion. The STAI-S scale had exhibited good
internal consistency (a ranging from 0.83 to 0.92). The STAI-T
scale measures a stable propensity to experience anxiety and
tendencies to perceive stressful situations as threatening. It
consists of 20 statements requiring individuals to rate how they
generally feel on a 4-point scale. The STAI scales have shown a
mean internal consistency score of 0.89 and mean test–retest
reliability of 0.88.[27] In both scales, higher scores indicate greater
state or trait anxiety.2.5. Hospital Anxiety and Depression Scale
TheHospitalAnxietyandDepressionScale (HADS) is a14-itemself-
report screening scale, 7 items for anxiety (HADS-A) and 7 for
depression (HADS-D), developed to indicate the presence of anxiety
and depression states.[28] Each item scores on a 4-point Likert scale
(0–3) giving a maximum subscale score of 21 for each scale.[29] The
HADS has shown good validity and reliability with values ranging
from 0.60 to 0.80.[30] In patients with TTH, the HADS has also
shown good internal consistency (Cronbach a: 0.84).[31]2.6. Statistical analysis
Data were analyzed with the SPSS statistical package (22.0
Version, SPSS Inc, Chicago, IL, USA). Descriptive data were
collected on all patients. The Kolmogorov–Smirnov test revealed
that quantitative data exhibited a normal distribution (P>0.05).
Differences in clinical data (i.e., frequency, intensity, or duration),
depression, anxiety, disability, and the number of TrPs (active or
latent TrP) between patients with FETTH or CTTHwere assessed
with the unpaired Student t test. The chi-square (x2) test was used
to analyze the differences in the distribution of TrPs (active or
latent) for each muscle within both groups. The Pearson
correlation test (r) was used to determine the association between
the number of active TrPs, depression (HADS-D), anxiety (HADS-
A, STAI-S, and STAI-T), burden (HDI-P and HDI-E), and clinicalTable 1
Clinical and demographic characteristics of patients with frequent e
Frequent episodic tension-type heada
Mean
Clinical data
Gender (male/female) 18/46
Age, y 44
Headache pain characteristics
Time of onset, y 10.3
Frequency, d/mo
∗
9.8
Intensity (NPRS, 0–10) 5.8
Duration, h/d† 6.6
Psychological outcomes
HDI-E (emotional, 0–52)
∗
14.3 1
HDI-P (physical, 0–48)
∗
19.1 1
HADS-D (depression, 0–21)
∗
7.4
HADS-A (anxiety, 0–21) 11.0
STAI-S (state, 0–60) 21.5 2
STAI-T (trait, 0–60) 23.8 2
CI = confidence interval, HADS = Hospital Anxiety and Depression Scale, HDI = Headache Disability In
∗
Significant differences between patients with frequent episodic and chronic tension-type headache (P
† Significant differences between patients with frequent episodic and chronic tension-type headache (P
3
variables relating to headache pain (frequency, intensity, and
duration). Correlations were considered weak when r<0.3,
moderate when 0.3< r<0.7, and strong when r>0.7.[32] The
statistical analysis was conducted at a 95% confidence level, and a
P value less than 0.05 was considered statistically significant.3. Results
3.1. Clinical data of the sample
From 160 eligible subjects with headache who accepted to
participated, 38 were excluded for the following reasons:
comorbid migraine (n=22), reporting previous neck trauma
(n=8), and fibromyalgia diagnosis (n=8). A total of 122
individuals with TTH were finally included. Sixty-two (51%)
were classified as FETTH, whereas the remaining 60 (49%) were
classified as CTTH accordingly to the ICHD-III. Fifty-five (45%)
patients were taking prophylactic drugs (i.e., amitriptyline) on a
regular basis. No changes were conducted on preventive
medication intake. Individuals with CTTH exhibited higher
frequency and longer duration, but similar intensity, of headache
attacks than those with FETTH (all, P<0.05). Further, CTTH
also showed higher burden of headache and depression than
FETTH (all P<0.001). No differences in anxiety levels were
observed (P>0.351). Table 1 shows the clinical data of each
group of people with TTH.
The HDI-P showed moderate-to-weak positive associations
with the intensity (r=0.345; P<0.001) and the frequency (r=
0.293; P<0.001) of headache: the higher the intensity or the
higher the frequency of TTH attacks, the higher the physical
burden of headache.3.2. Trigger points in tension-type headache
The mean±SD number of TrPs in the selected and examined
muscles for each patient with FETTH was 5.9±3.1 of which 4.7
±2.5 were active TrPs and the remaining 1.2±1.9 latent TrPs.
Similarly, each subject with CTTH showed a total number of 5.7
±3.2 (active: 4.2±3.0, latent: 1.5±1.8) TrPs. No significant
differences existed in the total number (t=1.294; P=0.198),pisodic and CTTH.
che (n=62) Chronic tension-type headache (n=60)
95% CI Mean 95% CI
17/43
40–48 46 42–50
7.3–10.3 8.4 5.5–11.3
8.8–10.9 26.5 25.8–27.3
5.3–6.3 5.9 5.5–6.4
5.6–7.7 8.5 7.4–9.6
1.8–16.9 25.7 22.0–29.4
6.4–21.7 26.9 23.5–30.4
6.3–8.3 9.9 8.6–11.1
9.9–12.2 10.3 9.0–11.5
0.3–22.7 21.7 20.4–23.1
2.2–25.4 23.5 21.7–25.3
ventory, STAI = State-Trait Anxiety Inventory.
<0.001).
<0.05).
Table 2
Individuals with frequent episodic and CTTH with TrPs.
Temporalis FETTH (n=62) Masseter FETTH (n=62) Sternocleidomastoid FETTH (n=62)
Right side Left side Right side Left side Right side Left side
Active TrPs (n, %) 45 (72.5%) 41 (66%) 14 (23%) 11 (18%) 23 (36.5%) 19 (30.5%)
Latent TrPs (n, %) 7 (11%) 7 (11%) 12 (19%) 14 (23%) 13 (22%) 16 (26%)
No TrPs (n, %) 10 (16.5%) 14 (23%) 36 (58%) 37 (59%) 26 (41.5%) 27 (43.5%)
Temporalis CTTH (n=60) Masseter CTTH (n=60) Sternocleidomastoid CTTH (n=60)
Right side Left side Right side Left side Right side Left side
Active TrPs (n, %) 38 (63%) 38 (63%) 10 (17%) 13 (22%) 17 (28%) 15 (25%)
Latent TrPs (n, %) 9 (15%) 7 (12%) 12 (20%) 7 (12%) 11 (18.5%) 11 (18.5%)
No TrPs (n, %) 13 (22%) 15 (25%) 38 (63%) 40 (66%) 32 (53.5%) 34 (56.5%)
Upper trapezius FETTH (n=62) Splenius capitis FETTH (n=62) Suboccipitalis FETTH (n=62)
Right side Left side Right side Left side Bilateral
Active TrPs (n, %) 30 (48%) 25 (40%) 31 (50%) 33 (53%) 14 (22.5%)
Latent TrPs (n, %) 9 (15.5%) 5 (8%) 4 (6.5%) 1 (1.5%) 12 (19%)
No TrPs (n, %) 23 (36.5%) 32 (52%) 27 (43.5%) 28 (45.5%) 36 (58.5%)
Upper trapezius CTTH (n=60) Splenius capitis CTTH (n=60) Suboccipitalis CTTH (n=60)
Right side Left side Right side Left side Bilateral
Active TrPs (n, %) 26 (43%) 20 (33%) 24 (40%) 27 (45%) 14 (23.5%)
Latent TrPs (n, %) 7 (12%) 5 (8.5%) 5 (8.5%) 4 (6.5%) 8 (13.5%)
No TrPs (n, %) 28 (45%) 35 (58.5%) 32 (51.5%) 29 (48.5%) 38 (63%)
CTTH = chronic tension-type headache, FETTH = frequent episodic tension-type headache, TrPs = trigger points.
Figure 1. Scatter plots of relationships between the number of active trigger
points with physical burden of headache (Headache Disability Inventory-P) (A)
and trait anxiety levels (State-Trait Anxiety Inventory-T) (B) (n=122). Note that
several points are overlapping. A positive linear regression line is fitted to the
data.
Palacios-Ceña et al. Medicine (2017) 96:13 Medicineactive (t=1.010; P=0.311), or latent (t=0.662; P=0.509) TrPs
between individual with FETTH or CTTH. The distribution of
TrPs in the analyzed muscles was not significantly different for
any muscle between patients with FETTH and CTTH (all, P>
0.414, Table 2). Active TrPs within the temporalis, splenius
capitis, and upper trapezius muscles were the most prevalent in
either individuals with FETTH or CTTH.
No associations were observed between the number of active
TrPs and any clinical pain feature, that is, intensity, frequency, or
duration of the headache (all, P>447). The number of active
TrPs was significantly and positively associated with burden of
headache (HDI-P: r=0.189; P=0.037; Fig. 1A) and trait anxiety
(STAI-T: r=0.273; P=0.005; Fig. 1B): the higher the number of
active TrPs, the greater the physical burden of headache, or the
more trait anxiety level independently of the TTH group. No
other association was observed (Table 3).
4. Discussion
The present study found that the presence of active TrPs in the
selected head and neck/shoulder muscles was similar between
individuals with FETTH and CTTH. Patients with CTTH
exhibited higher burden of headache and depression than those
with FETTH. The number of active TrPs was associated with the
physical burden of headache and trait anxiety levels.
The fact that individuals with CTTH exhibited higher burden
of headache than those with FETTH agrees with a recent study
showing that headache impact was higher in individuals with
higher headache frequency of headaches.[33] In fact, we also
observed a moderate association between the physical burden of
headache and the frequency of TTH attacks. Similarly, CTTH
was also associated with higher depressive symptoms than
FETTH. It seems that 70% of subjects with headache experience,
at sometime, depressive episodes[15] being more pronounced in
those patients with higher frequency of headaches.[34,35] An
unexpected finding of our study was that CTTH and FETTH4
individuals exhibited similar levels of anxiety. It is possible that
this lack of difference is related to the high frequency of attacks
that exhibited our group of FETTH patients.4.1. Trigger points in tension-type headache
The fact that the referred pain elicited by active TrPs reproduces
TTH pain is not new since previous studies also observed the
presence of active TrPs in this population.[9–14] Nevertheless,
Table 3
Pearson correlation coefficients between the number of active or latent TrPs and the remaining variables.
HDI-P HDI-E STAI-T STAI-S HADS-A HADS-D
Active TrPs r=0.189; P=0.037
∗
r=0.075; P=0.412 r=0.273; P=0.005
∗
r=0.021; P=0.830 r=0.006 P=0.950 r=0.084; P=0.357
Latent TrPs r=0.008; P=0.928 r=0.010; P=0.911 r=0.114; P=0.250 r=0.002; P=0.987 r=0.043; P=0.685 r=0.111; P=0.225
Age Time of onset Intensity Frequency Duration
Active TrPs r=0.093; P=0.385 r=0.044; P=0.635 r=0.069; P=0.447 r=0.055; P=0.550 r=0.006; P=0.946
Latent TrPs r=0.097; P=0.387 r=0.011; P=0.903 r=0.124; P=0.234 r=0.062; P=0.496 r=0.001; P=0.994
HDI = Headache Disability Inventory, STAI = State-Trait Anxiety Inventory, TrP = trigger point.
∗
Statistically significant (P<0.05).
Palacios-Ceña et al. Medicine (2017) 96:13 www.md-journal.comprevious studies included small sample sizes, and only 1
compared directly subjects with ETTH and CTTH.[14] Our
study is the first 1 investigating differences between FETTH and
CTTH using the updated diagnostic criteria (ICHD-III) and
including a considerable sample of participant. We did not find
differences in either the number or distribution of active TrPs
between subjects with FETTH or CTTH, in contrast which was
observed in a previous study.[14] A possible explanation for
discrepancy between our results and those reported by Sohn et
al[14] is that individuals with FETTH included in their study
exhibited lower frequency of headaches than our sample of
FETTH. It would be interesting to determine the presence of
active TrPs in subgroups of individuals with FETTH suffering
from different frequencies of headache.
The mechanism associating active TrPs with TTH has been
postulated by Fernández-de-las-Peñas et al[17] in an updated pain
model. In this model, sustained local contraction observed in the
TrP can promote hypoxia and ischemia, elevating the concen-
trations of algogenic substances and chemical mediators, for
example, calcitonin gene-related peptide, substance P, bradykinin
and serotonin, and consequently, and may lead to a peripheral
sensitization.[17] In fact, a microdialysis study supports the
hypothesis that active TrPs are associated with higher levels of
these and other chemical mediators near the TrP area.[36]
Therefore, when the craniocervical musculature has active TrP,
the nociceptive input driving to the trigeminocervical nucleus
caudalis may contribute to sensitization mechanisms observed in
TTH.[17] The present study supports that active TrPs are present
in FETTH in a similar manner as that in CTTH supporting that
active TrPs may contribute to central sensitization observed also
in the episodic form.[37] Current and previous evidence would
support that muscular factors may be responsible not only for the
acute headache episode but also for chronification of the pain.[38]
In fact, the potential relevance of active TrPs in TTH is supported
by the association of the number of active TrPs with the physical
burden of headache. Nevertheless, this association was weak (r<
0.2), and future clinical studies should investigate its clinical
relevance. This can be related to the fact that studies have not
been conclusive in terms of how blocking the nociception from
the TrPs affects the headache pain.[39]4.2. Trigger points and anxiety
This is the first study investigating the association of active TrPs
with mood disorders in TTH. An interesting finding was that the
number of active TrPs showed a small association with trait
anxiety. Previous studies have found that subjects with
temporomandibular myofascial pain report higher levels of
anxiety than healthy people[40,41] and that anxiety increases the
likelihood of muscle tenderness.[42] In fact, general distress has5
been identified as a risk factor for acute local muscle pain and
referred muscle pain using a standardized nociceptive input.[43]
This finding would support the fact that subjects with higher trait
anxiety levels exhibited a greater number of active TrPs. This
hypothesis maybe also related to the fact that physiological
muscle recovery depends on trait anxiety levels.[44] Since absence
or delayed muscle relaxation is a potential mechanism for TrP
activation,[45] it is possible that higher trait anxiety levels
represent a risk factor for active TrPs. Finally, we do not currently
know the effect of TrP management in mood disorders; future
studies should investigate these hypotheses.4.3. Limitations
Although strengths of the present study include a large sample
size and the inclusion of both FETTH and CTTH patients
according to the most updated diagnostic criteria, we should
recognize some potential limitations. First, we did not conduct a
sample size power analysis; so it is possible that some analyses
were underpowered. However, since we included the biggest
sample of patients with TTH investigating the role of TrPs in this
population, we believe that the inclusion of more individuals
would not alter the direction of our findings. Second, patients
were recruited from tertiary care hospitals; therefore, it is possible
that they represent a specific subgroup of the general population
with TTH. Third, the cross-sectional nature of the study does not
permit to establish a cause and effect relationship between active
TrPs and physical burden of headache and trait anxiety levels in
this population. Finally, the reliability of TrP diagnostic criteria is
questioned since some systematic reviews concluded that the
reliability varied widely depending, not only on the diagnostic
criteria or on the muscle evaluated, but also across various
studies.[46,47] However, it is important to consider that previous
reviews did not include any study specifically reporting the
reliability of TrP identification, only the reliability of each
diagnostic criteria in isolation.[46,47] In fact, recent studies have
reportedmoderate-to-excellent reliability for TrP diagnosis based
on the presence of an experienced assessor[48,49] and the
combination of the diagnostic criteria used in the present
study.[50,51]5. Conclusion
The presence of active TrPs in selected head and neck/shoulder
muscles was similar between people with FETTH or CTTH.
Patients with CTTH exhibited higher burden of headache
and depression than those with FETTH. The number of active
TrPs was positively associated with the physical burden of
headache and trait anxiety in both individuals with CTTH and
FETTH.
[28] Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta
Palacios-Ceña et al. Medicine (2017) 96:13 MedicineReferences
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